Search Results - "Foley, Keira"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL) by Chu, Yaya, Foley, Keira, Tian, Meijuan, Klose, Kayleigh, Ayala-Cuesta, Jessica, Lee, Dean Anthony, Marcondes, Mario, Klein, Christian, Cairo, Mitchell S.

    Published in Blood (02-11-2023)
    “…Background: We have previously reported the success of treating children with Burkitt lymphoma (BL) resulting in a ≥90% long-term EFS utilizing short intensive…”
    Get full text
    Journal Article
  2. 2

    Abstract 3615: Targeting high-risk neuroblastoma by TGFβ imprinted natural killer cells by Ayala-Cuesta, Jessica A., Chu, Yaya, Foley, Keira, Tian, Meijuan, Klose, Kayleigh, Mendelowitz, Alyssa S., Cripe, Timothy P., Lee, Dean A., Cairo, Mitchell S.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Background: Neuroblastoma (NB) is a common malignant extracranial solid tumor in children, responsible for 11% of cancer deaths in pediatric patients…”
    Get full text
    Journal Article
  3. 3

    IL15 (N-803) and IL21 (oHSV-21) Significantly Enhance ROR1 CAR NK Cells Against Pediatric Neuroblastoma by Chu, Yaya, Tian, Meijuan, Saini, Uksha, Ayala-Cuesta, Jessica, Klose, Kayleigh, Foley, Keira, Mendelowitz, Alyssa S., Cripe, Timothy P, Lee, Dean Anthony, Riddell, Stanley R., Cassady, Kevin A., Cairo, Mitchell S.

    Published in Transplantation and cellular therapy (01-02-2024)
    “…Metastatic and relapsed/refractory neuroblastoma (NB) has a very poor diagnosis. Novel therapies are desperately needed. ROR1 is overexpressed in a variety of…”
    Get full text
    Journal Article
  4. 4